Hydrocortamate
 | |
| Clinical data | |
|---|---|
| Trade names | Magnacort, Ulcort |
| Routes of administration | Topical |
| Pharmacokinetic data | |
| Excretion | Hepatic |
| Identifiers | |
| |
| Synonyms | 11β,17α-Dihydroxy-3,20-dioxopregn-4-en-21-yl N,N-diethylglycinate |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| ECHA InfoCard | 100.000.877 |
| Chemical and physical data | |
| Formula | C27H41NO6 |
| Molar mass | 475.61754 g/mol |
| 3D model (JSmol) | |
| |
| |
Hydrocortamate (brand names Magnacort, Ulcortis) is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties.[1][2] It is used topically to treat inflammation due to corticosteroid-responsive dermatoses.[3]
References
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 317–. ISBN 978-1-4757-2085-3.
- ↑ Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 524–. ISBN 978-3-88763-075-1.
- ↑ DrugBank DB00769
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.